BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2324816)

  • 1. Association between number and sites of new bone scan abnormalities and presence of skeletal metastases in patients with breast cancer.
    Jacobson AF; Stomper PC; Jochelson MS; Ascoli DM; Henderson IC; Kaplan WD
    J Nucl Med; 1990 Apr; 31(4):387-92. PubMed ID: 2324816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone scans with one or two new abnormalities in cancer patients with no known metastases: frequency and serial scintigraphic behavior of benign and malignant lesions.
    Jacobson AF; Cronin EB; Stomper PC; Kaplan WD
    Radiology; 1990 Apr; 175(1):229-32. PubMed ID: 2315486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone scans with one or two new abnormalities in cancer patients with no known metastases: reliability of interpretation of initial correlative radiographs.
    Jacobson AF; Stomper PC; Cronin EB; Kaplan WD
    Radiology; 1990 Feb; 174(2):503-7. PubMed ID: 2296659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone secondaries in breast cancer: the solitary metastasis.
    Boxer DI; Todd CE; Coleman R; Fogelman I
    J Nucl Med; 1989 Aug; 30(8):1318-20. PubMed ID: 2754488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic imaging of bone metastases].
    Scutellari PN; Addonisio G; Righi R; Giganti M
    Radiol Med; 2000 Dec; 100(6):429-35. PubMed ID: 11307503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern and distribution of bone metastases in common malignant tumors.
    Kakhki VR; Anvari K; Sadeghi R; Mahmoudian AS; Torabian-Kakhki M
    Nucl Med Rev Cent East Eur; 2013; 16(2):66-9. PubMed ID: 24068635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmune imaging of bone marrow in patients with suspected bone metastases from primary breast cancer.
    Duncker CM; Carrió I; Berná L; Estorch M; Alonso C; Ojeda B; Blanco R; Germá JR; Ortega V
    J Nucl Med; 1990 Sep; 31(9):1450-5. PubMed ID: 2168473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of 67 Ga and 99mTc (MDP) bone agent. A case report.
    Padmanabhan V; Lakshmanan AV; Shanta V
    Indian J Cancer; 1980 Dec; 17(4):258-60. PubMed ID: 6894438
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance of skeletal scintigraphy for oncological practice].
    Kampmann H; Buchelt L
    Rontgenblatter; 1983 Oct; 36(10):342-51. PubMed ID: 6227979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The distribution of skeletal metastases in breast and pulmonary cancer: concise communication.
    Wilson MA; Calhoun FW
    J Nucl Med; 1981 Jul; 22(7):594-7. PubMed ID: 7252563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibular findings in carcinoma prostate; a challenging situation for reporting physician.
    Rashid N; Javed MM; Hassan A
    J Pak Med Assoc; 2019 Oct; 69(10):1572-1573. PubMed ID: 31622322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healing flare in skeletal metastases from breast cancer.
    Janicek MJ; Hayes DF; Kaplan WD
    Radiology; 1994 Jul; 192(1):201-4. PubMed ID: 8208938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of quantitative and visual detection of new focal bone lesions.
    Pitt WR; Sharp PF
    J Nucl Med; 1985 Mar; 26(3):230-6. PubMed ID: 3156219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance and outcome of one or two rib lesions on bone scans in breast cancer patients without known metastases.
    Chen HH; Su WC; Guo HR; Lee BF; Su WR; Wu PS; Chiu NT
    Nucl Med Commun; 2003 Nov; 24(11):1167-74. PubMed ID: 14569171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of the number of bone scan abnormalities at the time of initial bone metastatic recurrence in breast carcinoma.
    Jacobson AF; Shapiro CL; Van den Abbeele AD; Kaplan WD
    Cancer; 2001 Jan; 91(1):17-24. PubMed ID: 11148555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small cell lung cancer: radionuclide bone scans for assessment of tumor extent and response.
    Levenson RM; Sauerbrunn BJ; Ihde DC; Bunn PA; Cohen MH; Minna JD
    AJR Am J Roentgenol; 1981 Jul; 137(1):31-5. PubMed ID: 6264774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on prognostic factors in bone metastases of breast cancer].
    Yamashita K
    Nihon Seikeigeka Gakkai Zasshi; 1988 Mar; 62(3):191-203. PubMed ID: 3392448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of bone and liver scans in surveying patients with breast cancer for metastatic disease.
    Evans DM; Wright DJ
    Am Surg; 1987 Oct; 53(10):603-5. PubMed ID: 2823653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Scintigraphic evaluation of the efficacy of treatment of cancer of the breast with bone metastases].
    Gabuniia RI; Godin VP; Gritsaĭ AA; Kirsanov AG; Aplevich NN
    Med Radiol (Mosk); 1989 Apr; 34(4):49-53. PubMed ID: 2540391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of serial bone scans in assessing response of bone metastases to systemic treatment.
    Citrin DL; Hougen C; Zweibel W; Schlise S; Pruitt B; Ershler W; Davis TE; Harberg J; Cohen AI
    Cancer; 1981 Feb; 47(4):680-5. PubMed ID: 6261915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.